How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?

ABSTRACT:

SUBMITTER: Pinchinat A 

PROVIDER: S-EPMC9521218 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature